A number of observations have led us to speculate as to the role of GDF15 in ME/CFS, considering it as a potential disease biomarker and perhaps a contributor to the symptomatology observed. Here, GDF15 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.